Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis.
Gros B, Ross H, Nwabueze M, Constantine-Cooke N, Derikx LAAP, Lyons M, O'Hare C, Noble C, Arnott ID, Jones GR, Lees CW, Plevris N.
Gros B, et al. Among authors: o hare c.
Therap Adv Gastroenterol. 2024 Jul 30;17:17562848241258372. doi: 10.1177/17562848241258372. eCollection 2024.
Therap Adv Gastroenterol. 2024.
PMID: 39086990
Free PMC article.